COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

Ali  Farhoudian; Alexander Baldacchino; Nicolas Clark; Gilberto Gerra; Hamed Ekhtiari; Geert Dom; Azarakhsh  Mokri; Mandana  Sadeghi; Pardis Nematollahi; Maryanne Demasi; Christian  Schütz; Seyed Mohammadreza Hashemian; Payam  Tabarsi; Susanna  Galea-Singer; Giuseppe  Carrà; Thomas  Clausen; Christos  Kouimtsidis; Serenella Tolomeo; Seyed Ramin  Radfar; Emran Mohammad  Razaghi

doi:10.32598/bcn.11.covid19.1

COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

Ali Farhoudian, Alexander Baldacchino, Nicolas Clark, Gilberto Gerra, Hamed Ekhtiari, Geert Dom, Azarakhsh Mokri, Mandana Sadeghi, Pardis Nematollahi, Maryanne Demasi, Christian Schütz, Seyed Mohammadreza Hashemian, Payam Tabarsi, Susanna Galea-Singer, Giuseppe Carrà, Thomas Clausen, Christos Kouimtsidis, Serenella Tolomeo, Seyed Ramin Radfar, Emran Mohammad Razaghi

Research output: Contribution to journal › Article › peer-review

86 Citations (Scopus)

1024 Downloads (Pure)

Abstract

Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

Original language	English
Pages (from-to)	129-146
Number of pages	25
Journal	Autonomic Neuroscience: Basic and Clinical
Volume	11
Issue number	2
DOIs	https://doi.org/10.32598/bcn.11.covid19.1
Publication status	Published - 12 Apr 2020

Keywords

Coronavirus
Coronavirus Disease 2019 (COVID-19)
Pandemic
Public health
Substance use disorder
Addiction medicine
Harm reduction
Policy
Methadone
Opiod substitution therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.32598/bcn.11.covid19.1Licence: CC BY-NC

Final Published VersionFinal published version, 747 KBLicence: CC BY-NC

Cite this

Farhoudian, A., Baldacchino, A., Clark, N., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., Schütz, C., Hashemian, S. M., Tabarsi, P., Galea-Singer, S., Carrà, G., Clausen, T., Kouimtsidis, C., Tolomeo, S., Radfar, S. R., & Razaghi, E. M. (2020). COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper. Autonomic Neuroscience: Basic and Clinical, 11(2), 129-146. https://doi.org/10.32598/bcn.11.covid19.1

@article{01557436a9854cd39bf7da5b7f8bc5a1,

title = "COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper",

abstract = "Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).",

keywords = "Coronavirus, Coronavirus Disease 2019 (COVID-19), Pandemic, Public health, Substance use disorder, Addiction medicine, Harm reduction, Policy, Methadone, Opiod substitution therapy",

author = "Ali Farhoudian and Alexander Baldacchino and Nicolas Clark and Gilberto Gerra and Hamed Ekhtiari and Geert Dom and Azarakhsh Mokri and Mandana Sadeghi and Pardis Nematollahi and Maryanne Demasi and Christian Sch{\"u}tz and Hashemian, {Seyed Mohammadreza} and Payam Tabarsi and Susanna Galea-Singer and Giuseppe Carr{\`a} and Thomas Clausen and Christos Kouimtsidis and Serenella Tolomeo and Radfar, {Seyed Ramin} and Razaghi, {Emran Mohammad}",

year = "2020",

month = apr,

day = "12",

doi = "10.32598/bcn.11.covid19.1",

language = "English",

volume = "11",

pages = "129--146",

journal = "Autonomic Neuroscience: Basic and Clinical",

issn = "1566-0702",

publisher = "Elsevier",

number = "2",

}

Farhoudian, A, Baldacchino, A, Clark, N, Gerra, G, Ekhtiari, H, Dom, G, Mokri, A, Sadeghi, M, Nematollahi, P, Demasi, M, Schütz, C, Hashemian, SM, Tabarsi, P, Galea-Singer, S, Carrà, G, Clausen, T, Kouimtsidis, C, Tolomeo, S, Radfar, SR & Razaghi, EM 2020, 'COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper', Autonomic Neuroscience: Basic and Clinical, vol. 11, no. 2, pp. 129-146. https://doi.org/10.32598/bcn.11.covid19.1

COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper. / Farhoudian, Ali ; Baldacchino, Alexander; Clark, Nicolas et al.
In: Autonomic Neuroscience: Basic and Clinical, Vol. 11, No. 2, 12.04.2020, p. 129-146.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - COVID-19 and Substance Use Disorders

T2 - Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

AU - Farhoudian, Ali

AU - Baldacchino, Alexander

AU - Clark, Nicolas

AU - Gerra, Gilberto

AU - Ekhtiari, Hamed

AU - Dom, Geert

AU - Mokri, Azarakhsh

AU - Sadeghi, Mandana

AU - Nematollahi, Pardis

AU - Demasi, Maryanne

AU - Schütz, Christian

AU - Hashemian, Seyed Mohammadreza

AU - Tabarsi, Payam

AU - Galea-Singer, Susanna

AU - Carrà, Giuseppe

AU - Clausen, Thomas

AU - Kouimtsidis, Christos

AU - Tolomeo, Serenella

AU - Radfar, Seyed Ramin

AU - Razaghi, Emran Mohammad

PY - 2020/4/12

Y1 - 2020/4/12

N2 - Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

AB - Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

KW - Coronavirus

KW - Coronavirus Disease 2019 (COVID-19)

KW - Pandemic

KW - Public health

KW - Substance use disorder

KW - Addiction medicine

KW - Harm reduction

KW - Policy

KW - Methadone

KW - Opiod substitution therapy

U2 - 10.32598/bcn.11.covid19.1

DO - 10.32598/bcn.11.covid19.1

M3 - Article

C2 - 32855772

SN - 1566-0702

VL - 11

SP - 129

EP - 146

JO - Autonomic Neuroscience: Basic and Clinical

JF - Autonomic Neuroscience: Basic and Clinical

IS - 2

ER -

Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G et al. COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper. Autonomic Neuroscience: Basic and Clinical. 2020 Apr 12;11(2):129-146. doi: 10.32598/bcn.11.covid19.1

COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this